ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
GraniteShares YieldBOOST Biotech ETF
20.27
-0.0612
-0.30%
成交量:
722
成交額:
1.47萬
市值:
101.35萬
市盈率:
- -
高:
20.27
開:
20.27
低:
20.27
收:
20.33
52周最高:
25.28
52周最低:
20.27
股本:
5.00萬
流通股本:
5.00萬
量比:
0.34
換手率:
1.44%
股息:
4.92
股息率:
24.28%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI
新华财经
·
08/31
聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進
证券日报
·
08/30
南京諾令生物科技股份有限公司向港交所提交上市申請書,獨家保薦人為建銀國際。
智通财经
·
08/28
據港交所文件,維眸生物科技股份有限公司-B向港交所提交上市申請書。
智通财经
·
08/28
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BIOY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOY\",,,,,undefined,":{"symbol":"BIOY","market":"US","secType":"STK","nameCN":"GraniteShares YieldBOOST Biotech ETF","latestPrice":20.27,"timestamp":1789410862041,"preClose":20.3312,"halted":0,"volume":722,"delay":0,"changeRate":-0.0030101518847878866,"floatShares":50001,"shares":50001,"eps":0,"marketStatus":"交易中","change":-0.0612,"latestTime":"09-14 14:34:40 EDT","open":20.27,"high":20.27,"low":20.27,"amount":14666.91016,"amplitude":0,"askPrice":20.58,"askSize":100,"bidPrice":20.51,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":20.3312,"nav":20.361652,"aum":1018102.950152,"dividendRate":0.242827,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":20.61,"preClose":20.3312,"latestTime":"16:10 EDT","volume":6,"amount":121.9048,"timestamp":1789157404319,"change":0.2788,"changeRate":0.013713,"amplitude":0},"volumeRatio":0.342413},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOY\",,,,,undefined,":{"symbol":"BIOY","floatShares":50001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.342413,"shares":50001,"dividePrice":4.9221,"high":20.27,"amplitude":0,"preClose":20.3312,"low":20.27,"week52Low":20.27,"pbRate":"--","week52High":25.28,"institutionHeld":0,"latestPrice":20.27,"committee":0.333333,"eps":0,"divideRate":0.242827,"volume":722,"delay":0,"ttmEps":0,"open":20.27,"prevYearClose":25.12,"prevWeekClose":20.3312,"prevMonthClose":21.2744,"prevQuarterClose":23.15,"fiveDayClose":21.1669,"twentyDayClose":21.065,"sixtyDayClose":23.155},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOY\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"BIOY","amount":0.24645,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-15","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-15"},{"date":"2026-09-04","symbol":"BIOY","amount":0.24791,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-04","defaultRemindTime":1788528600000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-09","payableDate":"2026-09-04","currency":"USD","dateTimestamp":1788494400000,"payDate":"2026-09-09"},{"date":"2026-08-28","symbol":"BIOY","amount":0.24728,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-28","defaultRemindTime":1787923800000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-01","payableDate":"2026-08-28","currency":"USD","dateTimestamp":1787889600000,"payDate":"2026-09-01"},{"date":"2026-08-21","symbol":"BIOY","amount":0.24904,"announcedDate":"2026-08-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-21","defaultRemindTime":1787319000000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-25","payableDate":"2026-08-21","currency":"USD","dateTimestamp":1787284800000,"payDate":"2026-08-25"},{"date":"2026-08-14","symbol":"BIOY","amount":0.24507,"announcedDate":"2026-08-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-14","defaultRemindTime":1786714200000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-18","payableDate":"2026-08-14","currency":"USD","dateTimestamp":1786680000000,"payDate":"2026-08-18"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOY\",market:\"US\",,,undefined,":[{"executeDate":"2026-05-08","recordDate":"2026-05-08","paymentDate":"2026-05-12","value":0.28187,"currency":"USD"},{"executeDate":"2026-05-15","recordDate":"2026-05-15","paymentDate":"2026-05-19","value":0.29042,"currency":"USD"},{"executeDate":"2026-05-22","recordDate":"2026-05-22","paymentDate":"2026-05-27","value":0.2758,"currency":"USD"},{"executeDate":"2026-05-29","recordDate":"2026-05-29","paymentDate":"2026-06-02","value":0.27453,"currency":"USD"},{"executeDate":"2026-06-05","recordDate":"2026-06-05","paymentDate":"2026-06-09","value":0.2676,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663282078","title":"藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663282078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电(记者杜康)作为AI制药领域代表性企业之一,英硅智能(03696.HK)日前发布2026年度中期业绩报告。上半年,公司实现总营收1.063亿美元,同比增长287.2%;净利润3554万美元,经调整净利润5123万美元,经营活动现金流转正。这是英硅智能上市后发布的首份半年报,公司也由此前的亏损转为盈利。从收入结构看,药物研发与管线开发仍是主要来源。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CHAT","QTOC","BIOY","AGIX","GDOC","IPOS","LFSC","WRND","GSKH","APXH","BBP","BK4585","SBIO","IBB","XLVI","ARTY","AIPO","PBE","VTHR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044177","title":"聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044177","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 21:12","pubTimestamp":1788095520,"startTime":"0","endTime":"0","summary":"业绩实现扭亏为盈经营基本面持续改善今年上半年,联环药业经营业绩实现明显改善。对此,联环药业正持续推进相关工作。值得注意的是,联环药业已经开始围绕创新药商业化进行营销体系布局。除LH-1801外,联环药业产品注册申报也取得阶段性进展。从核心产品稳定销售,到集采品种持续放量,再到创新药研发向上市申报环节推进,联环药业正在逐步形成多层次的业务增长支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["WRND","GSKH","PBE","BK4588","LFSC","BBP","SBIO","BIOY","APXH","XLVI","BK4585","GDOC","IBB","BK0239","600513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091790","title":"南京諾令生物科技股份有限公司向港交所提交上市申請書,獨家保薦人為建銀國際。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662091790?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 22:53","pubTimestamp":1787928801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","BIOY","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662942093","title":"據港交所文件,維眸生物科技股份有限公司-B向港交所提交上市申請書。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662942093","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662942093?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:52","pubTimestamp":1787921537,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","IPOS","BIOY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BIOY\",params:#limit:6,delay:false,,,undefined,":[]}}